(Q35802787)

10 August 2017

Ribavirin and interferon alfa-2b in chronic hepatitis C: assessment of possible pharmacokinetic and pharmacodynamic interactions (English)

1 reference

10 August 2017

1 reference

1 reference

1 reference

1 reference

2

1 reference

10 August 2017

S Khakoo

1

1 reference

10 August 2017

L Grellier

3

1 reference

10 August 2017

B Wells

4

1 reference

10 August 2017

A Bell

5

1 reference

10 August 2017

C Dash

6

1 reference

10 August 2017

I Murray-Lyon

7

1 reference

10 August 2017

D Lypnyj

8

1 reference

10 August 2017

B Flannery

9

1 reference

10 August 2017

K Walters

10

1 reference

10 August 2017

G M Dusheiko

11

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 December 1998

1 reference

British Journal of Clinical Pharmacology

10 August 2017

1 reference

10 August 2017

46

1 reference

10 August 2017

563-570

1 reference

10 August 2017

6

1 reference

Ribavirin uptake by human erythrocytes and the involvement of nitrobenzylthioinosine-sensitive (es)-nucleoside transporters

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873804

Randomised, double-blind, placebo-controlled trial of interferon alpha-2b with and without ribavirin for chronic hepatitis C. The Swedish Study Group

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873804

Effects of interferon-alpha monotherapy on hepatic drug metabolism in cancer patients

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873804

Cloning of a human nucleoside transporter implicated in the cellular uptake of adenosine and chemotherapeutic drugs

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873804

Nucleoside and nucleobase transport systems of mammalian cells

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873804

Effects of cytokines on antiviral pharmacokinetics: an alternative approach to assessment of drug interactions using bioequivalence guidelines.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873804

Perspectives in the field of drug metabolism

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873804

A pilot study of combination therapy with ribavirin plus interferon alfa for interferon alfa-resistant chronic hepatitis C.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873804

Plasma disappearance, urine excretion, and tissue distribution of ribavirin in rats and rhesus monkeys

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873804

Ribavirin disposition in high-risk patients for acquired immunodeficiency syndrome.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873804

Pharmacokinetics of ribavirin and urinary excretion of the major metabolite 1,2,4-triazole-3-carboxamide in normal volunteers.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873804

Interferons and their actions

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873804

Pharmacokinetics and long-term tolerance to ribavirin in asymptomatic patients infected with human immunodeficiency virus

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873804

The role of neopterin as a monitor of cellular immune activation in transplantation, inflammatory, infectious, and malignant diseases

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873804

Ribavirin as therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1873804

Changes in interferon receptors on peripheral blood mononuclear cells from patients with chronic hepatitis B being treated with interferon

25 September 2018

1 reference

12 December 2020

Lack of pharmacokinetic interaction as an equivalence problem

1 reference

12 December 2020

Pharmacodynamics of biological response in vivo after single and multiple doses of interferon-beta

1 reference

12 December 2020

Serum levels of 2',5 oligoadenylate synthetase during interferon therapy in patients with B-cell chronic lymphocytic leukemia

1 reference

12 December 2020

10.1046/J.1365-2125.1998.00836.X

Identifiers

DOI

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/dzwq6usytvhnfgomouee4lqksm

30 July 2022

release_dzwq6usytvhnfgomouee4lqksm

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/dzwq6usytvhnfgomouee4lqksm

30 July 2022

https://api.fatcat.wiki/v0/release/dzwq6usytvhnfgomouee4lqksm

1 reference

30 July 2022

https://api.fatcat.wiki/v0/release/dzwq6usytvhnfgomouee4lqksm

1 reference

30 July 2022